ADVANCED LOCOREGIONAL MELANOMA

Clinical trials for ADVANCED LOCOREGIONAL MELANOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED LOCOREGIONAL MELANOMA trials appear

Sign up with your email to follow new studies for ADVANCED LOCOREGIONAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists test powerful Immune-Boosting combo against tough cancers

Disease control Recruiting now

This study is testing whether combining two existing cancer drugs—pembrolizumab and aldesleukin—works better than either alone for adults with advanced melanoma or kidney cancer that has stopped responding to standard treatments. The goal is to see if this combination can shrink …

Matched conditions: ADVANCED LOCOREGIONAL MELANOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

ADVANCED LOCOREGIONAL MELANOMA

Get alerted when new ADVANCED LOCOREGIONAL MELANOMA trials appear

Scientists test powerful Immune-Boosting combo against tough cancers